[go: up one dir, main page]

IT1254360B - Epitopi immunologicamente omologhi di hla e proteine del virus hiv. - Google Patents

Epitopi immunologicamente omologhi di hla e proteine del virus hiv.

Info

Publication number
IT1254360B
IT1254360B ITRM920350A ITRM920350A IT1254360B IT 1254360 B IT1254360 B IT 1254360B IT RM920350 A ITRM920350 A IT RM920350A IT RM920350 A ITRM920350 A IT RM920350A IT 1254360 B IT1254360 B IT 1254360B
Authority
IT
Italy
Prior art keywords
hla
immunologically
epitopes
homological
hiv proteins
Prior art date
Application number
ITRM920350A
Other languages
English (en)
Inventor
Alberto Beretta
Original Assignee
San Romanello Centro Fond
Ist Superiore Sanita
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by San Romanello Centro Fond, Ist Superiore Sanita filed Critical San Romanello Centro Fond
Publication of ITRM920350A0 publication Critical patent/ITRM920350A0/it
Priority to ITRM920350A priority Critical patent/IT1254360B/it
Priority to AT93910325T priority patent/ATE188484T1/de
Priority to US08/335,733 priority patent/US6042831A/en
Priority to EP93910325A priority patent/EP0641357B1/en
Priority to CA002135630A priority patent/CA2135630C/en
Priority to DE69327529T priority patent/DE69327529T2/de
Priority to PCT/IT1993/000049 priority patent/WO1993023427A1/en
Publication of ITRM920350A1 publication Critical patent/ITRM920350A1/it
Application granted granted Critical
Publication of IT1254360B publication Critical patent/IT1254360B/it
Priority to US09/243,079 priority patent/US20020081566A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Sono descritti epitopi immunologicamente omologhi tra HLA e proteine di HIV, in particolare gp120, da utilizzarsi nella diagnostica e nella preparazione di vaccini.
ITRM920350A 1992-05-11 1992-05-11 Epitopi immunologicamente omologhi di hla e proteine del virus hiv. IT1254360B (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
ITRM920350A IT1254360B (it) 1992-05-11 1992-05-11 Epitopi immunologicamente omologhi di hla e proteine del virus hiv.
CA002135630A CA2135630C (en) 1992-05-11 1993-05-10 Hiv protein epitopes immunologically homologous to hla
US08/335,733 US6042831A (en) 1992-05-11 1993-05-10 Human immunodeficiency virus type 1 (HIV-1) GP160 epitopes that are immunologically homologous to epitopes located in the class I major histocompatibility complex (MHC) heavy chain α-1 domain
EP93910325A EP0641357B1 (en) 1992-05-11 1993-05-10 Hiv protein epitopes immunologically homologous to hla
AT93910325T ATE188484T1 (de) 1992-05-11 1993-05-10 Immunologisch mit hla homologe hiv protein epitope
DE69327529T DE69327529T2 (de) 1992-05-11 1993-05-10 Immunologisch mit HLA homologe HIV Protein Epitope
PCT/IT1993/000049 WO1993023427A1 (en) 1992-05-11 1993-05-10 Hiv protein epitopes immunologically homologous to hla
US09/243,079 US20020081566A1 (en) 1992-05-11 1999-02-02 Hiv protein epitopes immunologically homologous to hla

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM920350A IT1254360B (it) 1992-05-11 1992-05-11 Epitopi immunologicamente omologhi di hla e proteine del virus hiv.

Publications (3)

Publication Number Publication Date
ITRM920350A0 ITRM920350A0 (it) 1992-05-11
ITRM920350A1 ITRM920350A1 (it) 1993-11-11
IT1254360B true IT1254360B (it) 1995-09-14

Family

ID=11400995

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM920350A IT1254360B (it) 1992-05-11 1992-05-11 Epitopi immunologicamente omologhi di hla e proteine del virus hiv.

Country Status (7)

Country Link
US (2) US6042831A (it)
EP (1) EP0641357B1 (it)
AT (1) ATE188484T1 (it)
CA (1) CA2135630C (it)
DE (1) DE69327529T2 (it)
IT (1) IT1254360B (it)
WO (1) WO1993023427A1 (it)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254360B (it) * 1992-05-11 1995-09-14 San Romanello Centro Fond Epitopi immunologicamente omologhi di hla e proteine del virus hiv.
IT1264078B1 (it) * 1993-09-10 1996-09-10 San Romanello Centro Fond Uso di anticorpi anti-molecole hla classe i libere da beta-2 microglobulina per saggi di evidenziazione dell'esposizione al virus
CN1339320A (zh) * 2000-08-18 2002-03-13 清华大学 一种艾滋病疫苗及其制备方法与应用
US7923209B2 (en) 2003-03-14 2011-04-12 Anergis, S.A. Allergen peptide fragments and use thereof
ES2625406T3 (es) 2010-03-25 2017-07-19 Oregon Health & Science University Glicoproteínas de CMV y vectores recombinantes
SMT201800284T1 (it) 2011-06-10 2018-07-17 Univ Oregon Health & Science Glicoproteine cmv e vettori ricombinanti
CA2789539A1 (en) 2011-09-12 2013-03-12 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
EP2586461A1 (en) 2011-10-27 2013-05-01 Christopher L. Parks Viral particles derived from an enveloped virus
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
EP2848937A1 (en) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Methods of identifying novel HIV-1 immunogens
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3072901A1 (en) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
WO2017152144A1 (en) * 2016-03-03 2017-09-08 Duke University Swarm immunization with envelopes from ch505

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4943628A (en) * 1988-06-13 1990-07-24 Ortho Pharmaceutical Corporation HIV peptide-inducted T cell stimulation
AU641814B2 (en) * 1990-09-25 1993-09-30 Peptech (Uk) Limited Aids therapy and vaccine
JPH06501260A (ja) * 1990-09-27 1994-02-10 シンテロ　ヴァクシーン　ディベロップメント　ケービー ヒト免疫不全ウィルスに対する中和抗体の誘発とワクチン接種に用いられるペプチド
IT1254360B (it) * 1992-05-11 1995-09-14 San Romanello Centro Fond Epitopi immunologicamente omologhi di hla e proteine del virus hiv.

Also Published As

Publication number Publication date
ITRM920350A0 (it) 1992-05-11
US6042831A (en) 2000-03-28
ATE188484T1 (de) 2000-01-15
DE69327529D1 (de) 2000-02-10
WO1993023427A1 (en) 1993-11-25
US20020081566A1 (en) 2002-06-27
CA2135630C (en) 2005-03-22
CA2135630A1 (en) 1993-11-25
DE69327529T2 (de) 2000-08-10
EP0641357B1 (en) 2000-01-05
EP0641357A1 (en) 1995-03-08
ITRM920350A1 (it) 1993-11-11

Similar Documents

Publication Publication Date Title
IT1254360B (it) Epitopi immunologicamente omologhi di hla e proteine del virus hiv.
MX9203439A (es) Una citocina mamifera, il-11
WO1999033868A3 (en) Human papillomavirus vaccine
DE68927348D1 (de) Künstlicher impfstoff gegen aids-virus
MY103182A (en) Vaccines against acquired immune deficiency syndrome.
DK0584348T3 (da) Genetisk vaccine mod immundefektvirusser
DE69111440D1 (de) Methoden und zusammensetzungen zur impfung gegen hiv.
DE69535018D1 (de) Papillomavirus vakzine
DK0541692T3 (da) Herpes simplex virus VP-16-vacciner
EA199800272A1 (ru) Фактор, стимулирующий дендритные клетки
ES8207429A1 (es) Un procedimiento para la preparacion de un polisacarido antigenico.
EP0306219A3 (en) Novel hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
DE69933875D1 (de) Protein-verabreichungssystem, das dem menschlichen papillomavirus ähnliche partikel benützt.
ATE341339T1 (de) Zusammensetzungen von rekombinanten papillomavirus vakzinen
FI890603A0 (fi) Menetelmä HIV-hiukkasimmunogeenin ja sen vasta-aineen valmistamiseksi
DK90090A (da) Fremgangsmaade til fremstilling af naturligt hiv gp160
AU5573196A (en) A pluripotent vaccine against enveloped viruses
MY104530A (en) Nonreplicating recombinant-made retroviral particles useful as anti-viral agents and as immunogens for pro- phylaxis and therapy against human retroviruses.
ES2017258A6 (es) Un metodo para producir peptidos antigenicos relacionados con el antigeno p97 asociado a melanoma.
DK284389A (da) Precursorantigener
ES2155436T3 (es) Proteinas recombinantes con la reactividad inmunologica del antigeno e del virus de la hepatitis b (hbeag), procedimiento para su preparacion y su utilizacion en analisis inmunologicos y en vacunas.
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960419